The new facility is located close to ADM’s pioneering research and development centre in the University of Valencia Scientific Park
ADM, one of the world’s leaders in science-backed nutrition solutions, has opened a new production facility in Valencia, Spain to help meet rising global demand for probiotics, postbiotics and other products that support health and well-being.
The production facility represents an investment north of $30 million and a more than five-fold increase in ADM’s production capacity, increasing it to 50 metric tons per year. The facility will allow ADM to supply growing markets for probiotics and postbiotics in the US, Asia-Pacific and Europe. ADM expects its customer base will more than triple over the next five years as more people recognise the links between the gut microbiome and many aspects of health and look for products tailored to their specific needs.
The facility, the world’s first to produce both probiotics and postbiotics at the same site, will help the company fulfill its expansion strategy in the health and well-being sector. ADM is on its way to realising its ambition to increase health and wellness revenue from over $500 million in 2022 to $2 billion within 10 years.
The site will produce ADM’s award-winning probiotic BPL1 and the heat-treated BPL1 postbiotic, as well as other ADM proprietary strains, supplying a broad range of customers. It will also be able to support further growth in ADM’s UK-leading Bio-Kult brand of products.